Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB signaling in triple negative breast cancer [ChIP-Seq]. Estrogen receptor beta repurposes EZH2 to suppress oncogenic NFκB signaling in triple negative breast cancer [ChIP-Seq]
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA655222
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study was to elucidate the effects of ERβ on the genomic distribution of NFκB and RNA Polymerase II phospho-Ser2, as well as changes in H3K27me3, H3K27ac, in MDA-MB-231 triple negative breast cancer cells. Overall design: ERβ-expressing MDA-MB-231 cells were treated with ethanol vehicle or 1nM E2 for 5 days, followed by 30 minutes of 20ng/ml TNFα in replicates of 2.
创建时间：
2020-08-04
